ENTITY
Jiangsu Hengrui Medicine

Jiangsu Hengrui Medicine (600276 CH)

403
Analysis
Health Care • China
Jiangsu Hengrui Medicine Co., Ltd. develops, manufactures, and markets a variety of medicines and medicine packing materials. The Company's products include anti-tumor medicines, pain-killers, anti-infection medicines, aluminum foil, and other related products.
more
bullish•MSCI ACWI Index
•01 May 2020 07:54

Battleground Spot For Global Equities

The risk of a pullback remains very real, however at this point the weight of the evidence suggests a meaningful pullback is not imminent. We recap...

Logo
554 Views
Share
bullish•Cross Asset Strategy
•26 Apr 2020 05:09

China A-Share Strategy: What Are Mutual Funds Buying in 1Q? Tech and Pharma

Chinese fund managers have added more tech and pharma stocks than any other sectors in their portfolios in 1Q this year, according to the fund...

Logo
Roger Xie
408 Views
Share
bearish•Quantitative Analysis
•23 Mar 2020 14:52

SH/SZ Connect Flows: Hikvision, Mindray, Moutai, Hengrui

In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...

Logo
413 Views
Share
bullish•Quantitative Analysis
•17 Dec 2019 17:32

Shanghai/​​​Shenzhen Connect Flows: $3bn Inflows Ahead of Phase 1 Trade Deal

In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...

Logo
506 Views
Share
bullish•MSCI ACWI Index
•22 Nov 2019 05:57

Global Equity Strategy: Health Care Hitting On All Cylinders - Overweight

Global equities remain in a short-term consolidation phase, however we continue to believe the longer-term trend is up and to the right for the...

Logo
456 Views
Share
x